Today: 6 February 2026
Subscribe
Browse Category

NSE:NATCOPHARM News 1 December 2025 - 8 December 2025

Natco Pharma Share Price Today (8 December 2025): Q2 Results, Adcock Ingram Deal and 2026 Stock Outlook

Natco Pharma Share Price Today (8 December 2025): Q2 Results, Adcock Ingram Deal and 2026 Stock Outlook

Natco Pharma Limited (NSE: NATCOPHARM) is back in the spotlight as the stock trades lower on 8 December 2025 even while the company closes a landmark acquisition in South Africa and navigates life after its blockbuster Revlimid (lenalidomide) windfall. Around late morning on Monday, 8 December, Natco Pharma was trading near ₹908–₹910 on the NSE, down roughly 2.5–3% from Friday’s…
8 December 2025
····
Natco Pharma Share Price Today (2 December 2025): Rating Reaffirmed, USFDA Update, South Africa Deal and 2026 Stock Forecast

Natco Pharma Share Price Today (2 December 2025): Rating Reaffirmed, USFDA Update, South Africa Deal and 2026 Stock Forecast

Natco Pharma has had a busy few months: a big overseas acquisition in South Africa, a fresh USFDA inspection with Form 483 observations, strong-but-normalising earnings, and a credit-rating reaffirmation that reassured debt markets. The share price is finally stabilising after a brutal fall earlier in 2025, but the market is still arguing about what the stock is really worth. Below…
2 December 2025
····
Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Mumbai, 1 December 2025 — Natco Pharma Limited (NSE: NATCOPHARM, BSE: 524816) is back in the spotlight. The stock is seeing heavy trading, fresh institutional interest and a sharp intraday bounce, even as investors digest softer Q2 FY26 earnings, a recent USFDA inspection in Chennai and a large acquisition in South Africa. Natco Pharma share price today: sharp bounce with…
1 December 2025
····

Stock Market Today

  • Strathcona Resources Shares Fall Below 50-Day Moving Average Amid Mixed Analyst Ratings
    February 6, 2026, 12:10 PM EST. Shares of Strathcona Resources Ltd. (TSE:SCR) dropped below its 50-day moving average of C$32.28, trading as low as C$26.53. The stock last traded at C$27.15 on Thursday, with 287,608 shares changing hands. Analyst opinions vary: TD Securities and National Bank of Canada issue bullish outlooks with target prices of C$36.00 and strong-buy ratings, while Royal Bank of Canada and Jefferies suggest more cautious views. The company recently paid a quarterly dividend of C$0.30, yielding 4.4%. Strathcona Resources, a Canadian oil and gas producer focused on thermal oil and enhanced recovery, holds a market cap of C$5.87 billion. Its price-to-earnings ratio stands at 5.35, with a high beta of 2.61, indicating increased volatility.
Go toTop